ATE196290T1 - Pyridin- und pyrazindicarbonsäurederivate als zellwachstumsregulatoren - Google Patents

Pyridin- und pyrazindicarbonsäurederivate als zellwachstumsregulatoren

Info

Publication number
ATE196290T1
ATE196290T1 AT95941202T AT95941202T ATE196290T1 AT E196290 T1 ATE196290 T1 AT E196290T1 AT 95941202 T AT95941202 T AT 95941202T AT 95941202 T AT95941202 T AT 95941202T AT E196290 T1 ATE196290 T1 AT E196290T1
Authority
AT
Austria
Prior art keywords
pyrazinecarbonic
pyridine
cell growth
acid derivatives
growth regulators
Prior art date
Application number
AT95941202T
Other languages
English (en)
Inventor
Jessie Sandosham
Johann Hiebl
Hermann Kollmann
Alan Cuthbertson
Peter Fischer
Michael Hartmann
Peter Kremminger
Franz Rovenszky
Mette Husbyn
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Application granted granted Critical
Publication of ATE196290T1 publication Critical patent/ATE196290T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95941202T 1994-12-20 1995-12-20 Pyridin- und pyrazindicarbonsäurederivate als zellwachstumsregulatoren ATE196290T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9425730.0A GB9425730D0 (en) 1994-12-20 1994-12-20 Compounds
PCT/GB1995/002977 WO1996019457A1 (en) 1994-12-20 1995-12-20 Pyridine and pyrazinedicarboxylic-acid derivatives as cell proliferation regulators

Publications (1)

Publication Number Publication Date
ATE196290T1 true ATE196290T1 (de) 2000-09-15

Family

ID=10766245

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95941202T ATE196290T1 (de) 1994-12-20 1995-12-20 Pyridin- und pyrazindicarbonsäurederivate als zellwachstumsregulatoren

Country Status (8)

Country Link
US (2) US5972926A (de)
EP (1) EP0799208B1 (de)
AT (1) ATE196290T1 (de)
AU (1) AU4268696A (de)
DE (1) DE69518857T2 (de)
ES (1) ES2150021T3 (de)
GB (1) GB9425730D0 (de)
WO (1) WO1996019457A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425730D0 (en) * 1994-12-20 1995-02-22 Nycomed Pharma As Compounds
JP2001509795A (ja) * 1997-01-27 2001-07-24 ニィコメド・オーストリア・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 血液調節作用を有する新規化合物
US6184241B1 (en) * 1998-08-24 2001-02-06 Kansas State University Research Foundation Aspartic protease inhibitors
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
US6218408B1 (en) 1999-06-30 2001-04-17 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6340683B1 (en) 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
PT1183245E (pt) 1999-04-22 2007-07-12 Lundbeck & Co As H Antagonistas selectivos de npy (y5)
US6222040B1 (en) 1999-06-30 2001-04-24 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US6214853B1 (en) 1999-06-30 2001-04-10 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6225330B1 (en) 1999-06-30 2001-05-01 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US7273880B2 (en) 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
FR2843590B1 (fr) 2002-08-14 2007-10-05 Prestwick Scient Capital Inc Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique
JP2008543953A (ja) * 2006-04-20 2008-12-04 テバ ファーマシューティカル インダストリーズ リミティド エスゾピクロン結晶形態a、実質的に純粋なエスゾピクロン及び光学的に豊富なエスゾピクロンを調製するための方法
WO2008002629A1 (en) * 2006-06-26 2008-01-03 Teva Pharmaceutical Industries Ltd. Process for the preparation of zopiclone
US20080287447A1 (en) * 2007-01-31 2008-11-20 Nina Finkelstein Methods for preparing eszopiclone

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9211677D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211668D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9314200D0 (en) * 1993-07-09 1993-08-18 Hafslund Nycomed As Peptide compounds
EP0725651B1 (de) * 1993-10-29 1999-08-11 Smithkline Beecham Corporation Blutregulierende peptide
GB9324691D0 (en) * 1993-12-01 1994-01-19 Hafslund Nycomed As Peptide compounds
GB9425730D0 (en) * 1994-12-20 1995-02-22 Nycomed Pharma As Compounds

Also Published As

Publication number Publication date
GB9425730D0 (en) 1995-02-22
DE69518857T2 (de) 2001-04-26
EP0799208B1 (de) 2000-09-13
DE69518857D1 (de) 2000-10-19
ES2150021T3 (es) 2000-11-16
WO1996019457A1 (en) 1996-06-27
US5972926A (en) 1999-10-26
AU4268696A (en) 1996-07-10
EP0799208A1 (de) 1997-10-08
US6124298A (en) 2000-09-26

Similar Documents

Publication Publication Date Title
ATE196290T1 (de) Pyridin- und pyrazindicarbonsäurederivate als zellwachstumsregulatoren
DK0741710T3 (da) Chlorpyrimidin-mellemprodukter
MX9702658A (es) Derivados novedosos de acido carboxilico, su preparacion y uso.
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
MX9604378A (es) Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios.
MY109143A (en) Sulfonamido-and sulfonamidocarbonylpyridine 2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals
HUT76511A (en) Benzoyl derivatives, preparation and use thereot
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
ES8402827A1 (es) Procedimiento para la preparacion de nuevos compuestos de aroilimidazol-2-ona.
DE69702705D1 (de) Kondensierte pyrrolo(2,3-c) carbazole-6-one die die aktivität von gamma interferon potenzieren
MY115211A (en) Novel amino acid derivatives, their preparation and use
YU113391A (sh) 2,4 i 2,5 substituirani piridin-n oksidi i postupak za njihovu proizvodnju
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
ATE330613T1 (de) Verwendung von prostaglandin a oder dessen derivaten zur behandlung von psoriasis
YU13699A (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
DK540586A (da) Cardiotonisk virksomme thiazoloner
NZ335057A (en) Pentaerythritol derivatives, their production and use and intermediates for their synthesis
ATE79615T1 (de) Cardiotonische phenyloxazolone.
DK1051404T3 (da) Substituerede phenyluraciler med herbicid virkning
MD950100A (en) Substituted oximethers method of their preparation and application for pests and fungus control
NZ323207A (en) Hemoregulatory compounds
ES8507116A1 (es) Un procedimiento para preparar un alcoxiimino eter
RO116403B1 (ro) Derivaţi ai teofilinei şi teobrominei şi procedeu de preparare
GR3024709T3 (en) Novel cytarabine derivatives, their production and use